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Clinical Interventions in Aging and SARA
An organizational meeting of the International Society for Applied Research in Aging
(SARA) was held in Tampa, FL, USA on October 28 – 30, 2005. The new society
was created by and for practitioners of longevity medicine who seek evidence-based
information on clinical methods for improving and extending health, vitality and
quality of life during aging. Through application of these methods, onset of intrinsic
diseases associated with senescence can be delayed and possibly prevented instead
of being treated after they occur. In support of this goal, the newly organized society
sponsored a scientific symposium entitled, Clinical Interventions in Aging (CIA), to
coincide with its organizational meeting. The title of the first Symposium was chosen
to be the same as this Journal, which is SARA’s official publication. Speakers were
experts in their respective fields, having published their work in peer-reviewed medical
and professional journals. Because it was the first annual SARA meeting, the program
was specifically designed to provide a broad-brush approach to the field of anti-
aging medicine. It began with a historical perspective of research data that originally
provided clues as to how life may be extended, and also how those insights eventually
reached clinical application. Methods with the potential to maintain homeostasis were
discussed. These focused primarily upon age-related decay of neurotransmitter
dynamics, neuroendocrine dysfunction, and the positive effects of caloric restriction.
Philosophical issues such as whether aging is a disease or a process were also debated.
Subsequent sessions extended the earlier research findings into present day anti-
aging applications including such diverse subjects as nutrition, exercise, lifestyle
and behavior, cosmetic surgery, dermatology, and even chelation. Although most of
the information conveyed was essentially a review of previously published data, new
findings were also presented as “hot topics” from investigators with studies either in
progress or recently finished but unpublished.
Because anti-aging medicine is not yet recognized as an established field of practice
by the traditional medical community, a session of the SARA symposium was devoted
to current controversies, especially involving ethical and legal aspects of certain
popular interventions such as human growth hormone replacement therapy (hGHRT).
Coincidentally, an article critical of using hGH as an intervention in aging was
published in the Journal of the American Medical Association (JAMA) just before
the meeting. Fortunately, one of the authors of the article was an invited speaker at
the Symposium. His presence ensured lively and informed debate in which both
sides of the issue were well represented. Although consensus was not achieved, it
was possible for those present to acknowledge that specific federal guidelines restrict
hGH use to only a few indications, while also recognizing that it is possible to comply
with the Code of Federal Regulations (CFR) covering hGH use within the context of
longevity medicine.
After conclusion of the educational program, a business meeting of the founding
SARA membership was held. It was agreed that because of the inevitable growth of
anti-aging medicine, an effort should be made to develop affiliate memberships with
similarly minded organizations around the world. Initially, Dr. Fiorenzo Angehrn,
one of SARA’s founding members and President of a Swiss anti-aging society
announced that many of his local members expressed such a desire. Since the meeting,Clinical Interventions in Aging 2006:1(2) 98
affiliation meetings have been held with Drs. Tsubota,
Marotta, and Naim, who are presidents of their own anti-
aging groups in Japan, Italy, and Switzerland, respectively.
As with Dr. Angehrn, they pledged to promote affiliation of
their membership with SARA and two of them have accepted
positions on the CIA editorial board in support of the effort.
In recognition of these affiliate memberships, the publisher
has agreed to designate CIA as the official, English-language
journal for each society. Thus, the result of our efforts to
organize an international, ethical, and relevant society for
anti-aging practitioners was encouraging. With continued
support of the membership, SARA should grow and flourish
as a model for good clinical practice through education and
service in the coming months and years.